07:00 , Jul 17, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Schizophrenia G protein-coupled receptor 52 (GPR52) In vitro and mouse studies suggest agonizing GPR52 could help treat schizophrenia, which is highly expressed in brain regions...